Cardiovascular Health

Janssen Pharmaceutical Companies submitted a supplemental New Drug Application (sNDA) to the FDA to expand the use of rivaroxaban in patients with peripheral artery disease.

Angiotensin receptor II blockers are often prescribed to control hypertension or for heart failure, kidney failure, or following a heart attack.

RG is a male patient aged 45 years who has arrived at the pharmacy to pick up his regular maintenance medications after recently losing 45 pounds in 3 months.

The objective for researchers in the new study was to determine whether the findings were generalizable in other populations by conducting a similar analysis in the United States, focusing on death from cardiovascular disease.

Lipid-lowering medication may be an effective adjuvant cancer therapy.

The relationship between the flu and heart disease is of particular concern during the pandemic, as severe COVID-19 outcomes have also been associated with exacerbated cardiovascular conditions.

Cholesterol-lowering statins have been found to potentially reduce the risk of cancer via a pathway that is unrelated to its impact on cholesterol, according to a recent study.

Study shows that more than half of older patients hospitalized for heart failure are discharged with 10 or more prescriptions, putting them at significant risk for harm related to high medication burden.

After hospital admittance, the number of patients with heart failure who are on 10 or more medications rises.

This activity is supported by an educational grant from Portola Pharmaceuticals, Inc.

Women found to have worse outcomes after a first heart attack than men.

Heart attack, stroke, stent placement, or heart failure hospitalization occurred in 5.3% of the telemonitored group compared with 10.4% of the routine primary care group.

Researchers found that the children of women with preeclampsia had higher systolic blood pressure on average.

Women with 2 or more moderate to severe menopause symptoms are at a heightened risk of cardiovascular disease and stroke.

Two groups of medications that are generally prescribed to treat type 2 diabetes have been found to reduce risks associated with chronic kidney disease and cardiovascular disease.

Understanding risk factors and treatments for irregular heart rhythms may be especially important during the COVID-19 pandemic.

Conduct proper review and evaluation of ARV and DOAC pharmacokinetics and metabolism prior to recommending treatment.

Pharmacy Times® spoke with Jenine Abuzir, PharmD candidate at Chicago College of Pharmacy at Midwestern University, about her experience teaching in the Women’s Health elective during pharmacy school.

What would you recommend to these patients?

Researchers found the largest decreases for heart attack risk among women, which may be because of greater attention paid to women’s heart health in recent decades.

A new study found that hypertension is a common comorbidity in patients with COVID-19.

Top news of the week from Pharmacy Times®.

Researchers found that although the number of Medicare beneficiaries increased between 2014 and 2018, total costs decreased.

Mindfulness training may hold the key to reducing the risk of cardiovascular disease, which is rapidly becoming the leading cause of death worldwide.

Individuals with a higher risk of cardiovascular disease (CVD) demonstrate an increase in cognitive decline, including a rise in the typical markers of Alzheimer disease, according to the results of a recent study.

Mailing educational materials to patients with atrial fibrillation and their clinicians did not increase the use of stroke prevention drugs.

Patients reported their likeness of having support from a trusted health care professional, rapid feedback, and adjustments to their treatment with someone to be accountable to, according to the study authors.

Research suggests ketogenic and intermittent fasting diets seem to help people lose weight in the short-term, which benefits cardiovascular health.

A pacemaker may help reduce or eliminate the risk of fainting in certain patients

Although the adverse effects of the lockdown were inevitable for cardiology patients, increased technology services may offer an opportunity for expanded patient access.